Amrutanjan Health Care Limited (NSE:AMRUTANJAN)
664.75
+5.00 (0.76%)
Jul 29, 2025, 3:30 PM IST
Amrutanjan Health Care Revenue
In the fiscal year ending March 31, 2025, Amrutanjan Health Care had annual revenue of 4.69B INR with 11.42% growth. Amrutanjan Health Care had revenue of 1.35B in the quarter ending March 31, 2025, with 6.45% growth.
Revenue
4.69B
Revenue Growth
+11.42%
P/S Ratio
4.09
Revenue / Employee
7.41M
Employees
634
Market Cap
19.22B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 4.69B | 481.24M | 11.42% |
Mar 31, 2024 | 4.21B | 416.12M | 10.96% |
Mar 31, 2023 | 3.80B | -261.89M | -6.45% |
Mar 31, 2022 | 4.06B | 729.35M | 21.90% |
Mar 31, 2021 | 3.33B | 712.64M | 27.23% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 525.78B |
Divi's Laboratories | 93.60B |
Cipla | 274.80B |
Mankind Pharma | 122.07B |
Apollo Hospitals Enterprise | 217.94B |
Zydus Lifesciences | 232.42B |
Aurobindo Pharma | 317.24B |
Fortis Healthcare | 77.86B |